DOCSLIB.ORG

CHAPTER Gynaecological Procedures 13

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Institutul National de Cercetare-Dezvoltare in Sanatate / Centrul de Calcul, Statistica Sanitara si Documentare Medicala CHAPTER 13 Gynaecological Procedures BLOCK 1240 Application, insertion or removal procedures on ovary 35518-00 Aspiration of ovarian cyst BLOCK 1241 Incision procedures on ovary 35637-08 Laparoscopic ovarian drilling 35713-03 Ovarian drilling 35637-07 Laparoscopic rupture of ovarian cyst or abscess 35713-02 Rupture of ovarian cyst or abscess BLOCK 1242 Biopsy of ovary 35637-06 Biopsy of ovary BLOCK 1243 Oophorectomy 35638-03 Laparoscopic oophorectomy, bilateral 35638-02 Laparoscopic oophorectomy, unilateral 35638-01 Laparoscopic partial oophorectomy 35638-00 Laparoscopic wedge resection of ovary 35713-07 Oophorectomy, unilateral 35717-01 Oophorectomy, bilateral 35713-05 Wedge resection of ovary 35713-06 Partial oophorectomy BLOCK 1244 Other excision procedures on ovary 35638-05 Laparoscopic ovarian cystectomy, bilateral 35638-04 Laparoscopic ovarian cystectomy, unilateral 35713-04 Ovarian cystectomy, unilateral 35717-00 Ovarian cystectomy, bilateral BLOCK 1245 Transposition of ovary 35729-01 Transposition of ovary 35729-00 Laparoscopic transposition of ovary BLOCK 1246 Other repair procedures on ovary 90430-01 Other repair of ovary 90430-00 Other laparoscopic repair of ovary BLOCK 1247 Other procedures on ovary 90431-00 Other procedures on ovary BLOCK 1248 Application, insertion or removal procedures on fallopian tube 35710-00 Falloposcopy 35703-01 Therapeutic hydrotubation BLOCK 1249 Incision procedures on fallopian tube 35694-02 Laparoscopic salpingolysis 35638-06 Laparoscopic salpingotomy 35694-06 Salpingolysis CHAPTER 13 Gynaecological Procedures Pagina 1 din 7 Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Institutul National de Cercetare-Dezvoltare in Sanatate / Centrul de Calcul, Statistica Sanitara si Documentare Medicala 35713-12 Salpingotomy BLOCK 1250 Biopsy of fallopian tube 90432-00 Biopsy of fallopian tube BLOCK 1251 Salpingectomy 35713-08 Partial salpingectomy, unilateral 35638-07 Laparoscopic partial salpingectomy, unilateral 35638-08 Laparoscopic partial salpingectomy, bilateral 35638-09 Laparoscopic salpingectomy, unilateral 35717-02 Partial salpingectomy, bilateral 35713-09 Salpingectomy, unilateral 35638-10 Laparoscopic salpingectomy, bilateral 35717-03 Salpingectomy, bilateral BLOCK 1252 Salpingo-oophorectomy 35638-13 Laparoscopic unilateral oophorectomy with bilateral salpingectomy 35638-12 Laparoscopic salpingo-oophorectomy, bilateral 35638-11 Laparoscopic salpingo-oophorectomy, unilateral 35713-11 Salpingo-oophorectomy, unilateral 35717-05 Unilateral oophorectomy with bilateral salpingectomy 35717-04 Salpingo-oophorectomy, bilateral BLOCK 1253 Salpingoplasty 35697-00 Microsurgical salpingoplasty 35694-00 Laparoscopic salpingoplasty 35694-04 Salpingoplasty BLOCK 1254 Anastomosis of fallopian tube 35694-05 Anastomosis of fallopian tube 35694-01 Laparoscopic anastomosis of fallopian tube BLOCK 1255 Other repair procedures on fallopian tube 35694-03 Laparoscopic salpingostomy 35694-07 Salpingostomy 90433-01 Other repair of fallopian tube 90433-00 Other laparoscopic repair of fallopian tube BLOCK 1256 Procedures for management of ectopic pregnancy 35674-00 Fetotoxic injection of ectopic pregnancy using ultrasound guidance 35678-01 Laparoscopic salpingectomy with removal of tubal pregnancy 35678-00 Laparoscopic salpingotomy with removal of tubal pregnancy 35677-05 Salpingectomy with removal of tubal pregnancy 35674-01 Fetotoxic injection of ectopic pregnancy via laparoscopy 35677-01 Manual/hydrostatic expression of fallopian tube 35677-00 Removal of peritoneal ectopic pregnancy 35677-03 Fetotoxic management for removal of ectopic pregnancy 35677-02 Fetotoxic injection of ectopic pregnancy CHAPTER 13 Gynaecological Procedures Pagina 2 din 7 Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Institutul National de Cercetare-Dezvoltare in Sanatate / Centrul de Calcul, Statistica Sanitara si Documentare Medicala 35677-04 Salpingotomy with removal of tubal pregnancy BLOCK 1257 Procedures for female sterilisation 35688-03 Laparoscopic electrodestruction of fallopian tubes 35688-02 Sterilisation by open abdominal approach 35688-04 Electrodestruction of fallopian tubes 35688-00 Laparoscopic sterilisation 35688-01 Sterilisation via vaginal approach BLOCK 1258 Other procedures on fallopian tube 35703-00 Test for tubal patency 90434-00 Other procedures on fallopian tube BLOCK 1259 Examination procedures on uterus 35630-00 Diagnostic hysteroscopy BLOCK 1260 Insertion or removal of intrauterine device 35506-00 Replacement of intrauterine device [IUD] 35503-00 Insertion of intrauterine device [IUD] 35506-02 Removal of intrauterine device [IUD] BLOCK 1261 Other application, insertion or removal procedures on uterus 35633-02 Hysteroscopy with tubal catheterisation BLOCK 1262 Incision procedures on uterus 35633-00 Division of intrauterine adhesions 35649-00 Hysterotomy 35649-02 Division of uterine septum via hysterotomy 35634-00 Division of uterine septum via hysteroscopy BLOCK 1263 Destruction procedures on uterus 35622-00 Endoscopic endometrial ablation BLOCK 1264 Biopsy of endometrium 35620-00 Biopsy of endometrium BLOCK 1265 Curettage of uterus 35640-01 Curettage of uterus without dilation 35640-00 Dilation & curettage of uterus [D&C] BLOCK 1266 Excision of uterine lesion 35623-00 Uterine myomectomy via hysteroscopy 35633-01 Uterine polypectomy via hysteroscopy 35649-03 Uterine myomectomy 35649-01 Uterine myomectomy via laparoscopy 90452-00 Excision of other lesion of uterus BLOCK 1267 Evacuation of gravid uterus 35643-01 Suction curettage of uterus 35643-00 Dilation and curettage [D&C] following abortion or for termination of pregnancy CHAPTER 13 Gynaecological Procedures Pagina 3 din 7 Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Institutul National de Cercetare-Dezvoltare in Sanatate / Centrul de Calcul, Statistica Sanitara si Documentare Medicala 35643-02 Dilation and evacuation of uterus [D&E] BLOCK 1268 Abdominal hysterectomy 35653-01 Total abdominal hysterectomy 35653-02 Abdominal hysterectomy with unilateral salpingo-oophorectomy 35653-00 Subtotal abdominal hysterectomy 35661-00 Abdominal hysterectomy with extensive retroperitoneal dissection 35653-03 Abdominal hysterectomy with bilateral salpingo-oophorectomy 35664-00 Radical abdominal hysterectomy with radical excision of pelvic lymph nodes 35670-00 Abdominal hysterectomy with radical excision of pelvic lymph nodes 35667-00 Radical abdominal hysterectomy BLOCK 1269 Vaginal hysterectomy 35673-00 Vaginal hysterectomy with unilateral salpingo-oophorectomy 35756-02 Laparoscopically assisted vaginal hysterectomy proceeding to abdominal hysterectomy with bilateral salpingo-oophorectomy 35756-01 Laparoscopically assisted vaginal hysterectomy proceeding to abdominal hysterectomy with unilateral salpingo-oophorectomy 35756-00 Laparoscopically assisted vaginal hysterectomy proceeding to abdominal hysterectomy 35753-00 Laparoscopically assisted vaginal hysterectomy with unilateral salpingo-oophorectomy 35750-00 Laparoscopically assisted vaginal hysterectomy 35657-00 Vaginal hysterectomy 35664-01 Radical vaginal hysterectomy with radical excision of pelvic lymph nodes 35753-01 Laparoscopically assisted vaginal hysterectomy with bilateral salpingo-oophorectomy 35667-01 Radical vaginal hysterectomy 35673-01 Vaginal hysterectomy with bilateral salpingo-oophorectomy BLOCK 1270 Other excision procedures on uterus 35658-00 Debulking of uterus preceding hysterectomy 90443-00 Other excision of uterus BLOCK 1271 Uterine suspension procedures 35637-04 Laparoscopic ventrosuspension 35684-01 Uterine suspension 90435-00 Other laparoscopic repair of uterus 35684-00 Other laparoscopic uterine suspension 90435-01 Other repair of uterus BLOCK 1272 Reconstruction procedures on uterus and supporting structures 35680-01 Reconstruction of uterus and supporting structures 35680-00 Laparoscopic reconstruction of uterus and supporting structures BLOCK 1273 Other procedures on uterus 90436-00 Other procedures on uterus BLOCK 1274 Application, insertion or removal procedures on cervix 16512-00 Removal of cervical suture 16511-00 Insertion of cervical suture BLOCK 1275 Destruction procedures on cervix CHAPTER 13 Gynaecological Procedures Pagina 4 din 7 Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Institutul National de Cercetare-Dezvoltare in Sanatate / Centrul de Calcul, Statistica Sanitara si Documentare Medicala 35539-02 Laser destruction of lesion of cervix 35646-00 Radical diathermy of cervix 35608-00 Cautery of cervix 35608-01 Other destruction of lesion of cervix 35647-00 Large loop excision of transformation zone [LLETZ] BLOCK 1276 Excision procedures on cervix 35612-00 Removal of stump of cervix, abdominal approach 35608-02 Biopsy of cervix 35611-00 Cervical polypectomy 35613-00 Removal of stump of cervix, vaginal approach 35618-04 Amputation of cervix 35618-00 Cone biopsy of cervix 35618-01 Cone biopsy of cervix by laser BLOCK 1277 Repair procedures on cervix 35618-02 Repair of cervix 35640-02 Dilation of cervix BLOCK 1278 Other procedures on cervix 35618-03 Other procedures on cervix BLOCK 1279 Examination procedures on vagina 35539-04 Vaginoscopy 35614-00 Colposcopy BLOCK 1280
Recommended publications
  • New Patient Paperwork: Women

    New Patient Paperwork: Women

    The Texas Center for Reproductive Acupuncture ______________________________________________________________ Patient Intake Form: Women __________________________________________________________________________________________________________________________________________________________________________________________________________________ Important: The information on this form will help your acupuncturist to give you the best and most comprehensive care possible. It is important for you to complete this document as thoroughly as possible. Even though some of the questions may seem completely unrelated to your condition, they may play a contributing, or underlying role in diagnosis and treatment of your problem. __________________________________________________________________________________________________________________________________________________________________________________________________________________ General Patient Information (All of the information provided is strictly confidential – see permission to share medical information section) Last Name: _____________________________ First Name: _______________________________ Middle Initial: _______ Age: ______ Primary Telephone Number: ____________________________________ Alternative Phone # ______________________________________ E-Mail: ____________________________________ Date of Birth ____ / _____ / _____ Today’s Date ___/___/_____ Number of Name of your Menstrual Cycle Pregnancies Age menstruation began: _______ Cesarean Births Ob/Gyn: __________________________________________
  • 720Bfaa8bc7b73a78aff36ddef00

    720Bfaa8bc7b73a78aff36ddef00

    MOLECULAR AND CLINICAL ONCOLOGY 12: 237-243, 2020 A comparative study on the short‑term clinical efficacy of the modified laparoscopic uterine comminution technique and traditional methods XIAOJUN SHI1, LIBING SHI2 and SONGYING ZHANG2 1Department of Gynecology, The First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314001; 2Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China Received April 28, 2019; Accepted December 13, 2019 DOI: 10.3892/mco.2020.1982 Abstract. To assess the value of the modified laparoscopic diagnosis and treatment. It has thus become one of the most uterine comminution technique in laparoscopic uterine surgery, commonly used techniques in the field of gynecology. Uterine a total of 82 cases of laparoscopic myomectomy were divided fibroids are common benign tumors of the female genital into the traditional group and modified group, according to organs and the prevalence has been reported as high as 20 to a random number table. During the same period, 92 patients 40% (1,2). The widespread application of pulverizers allows who underwent laparoscopic hysterectomy were divided into for removal of uterine fibroids under laparoscopy, which better the conventional group and the modified group, according to a reflects the superiority of minimally invasive techniques. random number table. The patients in the conventional group However, preoperative diagnosis of uterine fibroids and and modified group who underwent laparoscopic uterine uterine sarcoma is very difficult. The incidence of uterine fibroid removal showed no significant differences in the fibroid sarcoma is approximately 0.03 to 1.00% (3).
  • Estimation of a Lower Bound for the Cumulative Incidence of Failure Of

    Estimation of a Lower Bound for the Cumulative Incidence of Failure Of

    CHAPTER 1 Introduction 11 1.1 Background The incidence of failure of a method for contraception is generally a matter of great interest to any person who uses, or whose sexual partner uses, that method. Not surprisingly, there is a large volume of research into the failure rates of all of the temporary methods for human contraception. However, there is a much more modest literature on the cumulative incidence of failure and annual failure rates of permanent sterilisation, particularly failures of female tubal sterilisation - often called “tubal ligation”, but including any means for occluding or interrupting the Fallopian tubes by surgical means. This is somewhat surprising given that female tubal sterilisation remains one of the most popular and widely used means of contraception. The Australian Study of Health and Relationships, which was conducted between May 2001 and June 2002 using a representative sample of 9,134 women aged 16 to 59 years, found that of the two-thirds of respondents who reported using some form of contraception, 22.5 per cent relied on tubal ligation or hysterectomy (these were not further distinguished), which was second in popularity only to oral contraceptives.1 The proportion of women in the 40-49 year age group who relied on tubal ligation or hysterectomy was 33 per cent, which was second in popularity only to vasectomy in the partner (34.6 per cent). In the 1995 United States Survey of Family Growth, conducted by the US National Center for Health Statistics, surgical sterilisation was the method of choice in
  • Minimally Invasive Surgery for Uterine Fibroids

    Minimally Invasive Surgery for Uterine Fibroids

    Ginekologia Polska 2020, vol. 91, no. 3, 149–157 Copyright © 2020 Via Medica REVIEW PAPER / GYNECOLOGY ISSN 0017–0011 DOI: 10.5603/GP.2020.0032 Minimally invasive surgery for uterine fibroids Yuehan Wang1 , Shitai Zhang1 , Chenyang Li2 , Bo Li1 , Ling Ouyang1 1Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China 2Shenyang Maternity and Child Health Hospital, Shenyang, China ABSTRACT The incidence of uterine fibroids, which comprise one of the most common female pelvic tumors, is almost 70–75% for women of reproductive age. With the development of surgical techniques and skills, more individuals prefer minimally invasive methods to treat uterine fibroids. There is no doubt that minimally invasive surgery has broad use for uterine fibroids. Since laparoscopic myomectomy was first performed in 1979, more methods have been used for uterine fibroids, such as laparoscopic hysterectomy, laparoscopic radiofrequency volumetric thermal ablation, and uterine artery emboliza- tion, and each has many variations. In this review, we compared these methods of minimally invasive surgery for uterine fibroids, analyzed their benefits and drawbacks, and discussed their future development. Key words: minimally invasive surgery; uterine fibroid; laparoscopic hysterectomy; laparoscopic myomectomy Ginekologia Polska 2020; 91, 3: 149–157 INTRODUCTION fibroids. They found that those two kinds of surgery did Uterine fibroids comprise one of the most common not have different recurrence risks, but that laparoscopic female pelvic tumors. When including the small, clinically myomectomy may be associated with less postoperative undetectable fibroids and microscopic fibroids, the incidence pain, lower postoperative fever, and shorter hospital stays is approximately 70–75% for those of reproductive age.
  • Co-Registered Multimodal Endoscope for Early Ovarian Cancer by David

    Co-Registered Multimodal Endoscope for Early Ovarian Cancer by David

    Co-registered Multimodal Endoscope for Early Ovarian Cancer by David Vega __________________________ Copyright © David Vega 2021 A Dissertation Submitted to the Faculty of the WYANT COLLEGE OF OPTICAL SCIENCES In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY In the Graduate College THE UNIVERSITY OF ARIZONA 2021 *$$)*&+!"**)++"&%&$$"++.)+"/+!+.!-)+!"**)++"&% ')')/ +"+# %)&$$%+!+"+'+*,#"##"% +!"**)++"&%)(,")$%+&)+! )&&+&)&!"#&*&'!/ +05/14/2021 + 05/14/2021 + "%#'')&-#%'+%&+!"*"**)++"&%"*&%+"% %+,'&%+!%"+0**,$"**"&% &+!"%#&'"*&+!"**)++"&%+&+! ),+&## !)/)+"/+!+ !-)+!"*"**)++"&%')'),%)$/")+"&%%)&$$% +!+"+'+*,#"##"% +!"**)++"&%)(,")$%+ +05/14/2021 "**)++"&%&$$"++!") 3 STATEMENT BY AUTHOR This dissertation has been submitted in partial fulfillment of the requirements for an advanced degree at the University of Arizona and is deposited in the University Library to be made available to borrowers under rules of the Library. Brief quotations from this dissertation are allowable without special permission, provided that an accurate acknowledgement of the source is made. Requests for permission for extended quotation from or reproduction of this manuscript in whole or in part may be granted by the head of the major department or the Dean of the Graduate College when in his or her judgment the proposed use of the material is in the interests of scholarship. In all other instances, however, permission must be obtained from the author. SIGNED: David Vega 4 DEDICATION A mi familia.
  • Obstetrics and Gynecology Clinical Privilege List

    Obstetrics and Gynecology Clinical Privilege List

    Obstetrics and Gynecology Clinical Privilege List Description of Service Alberta Health Services (AHS) Medical Staff who are specialists in Obstetrics and Gynecology (or its associated subspecialties) and have privileges in the Department of Obstetrics and Gynecology provide safe, high quality care for obstetrical and gynecologic patients in AHS facilities across the province. The specialty encompasses medical, surgical, obstetrical and gynecologic knowledge and skills for the prevention, diagnosis and management of a broad range of conditions affecting women's gynecological and reproductive health. Working to provide a patient-focused, quality health system that is accessible and sustainable for all Albertans, the department also offers subspecialty care including gynecological oncology, reproductive endocrinology, maternal fetal medicine, urogynecology, and minimally invasive surgery.1 Obstetrics and Gynecology privileges may include admitting, evaluating, diagnosing, treating (medical and/or surgical management), to female patients of all ages presenting in any condition or stage of pregnancy or female patients presenting with illnesses, injuries, and disorders of the gynecological or genitourinary system including the ability to assess, stabilize, and determine the disposition of patients with emergent conditions consistent with medical staff policy regarding emergency and consultative call services. Providing consultation based on the designated position profile (clinical; education; research; service), and/or limited Medical Staff
  • Gynaecology – Scope of Clinical Practice

    Gynaecology – Scope of Clinical Practice

    Epworth HealthCare Gynaecology – Scope of Clinical Practice Gynaecology – Scope of Clinical Practice Clinical Institute: Women’s and Children’s Procedure Name Tier Adnexal surgery, including ovarian cystectomy, oophorectomy, salpingectomy, and Tier A conservative procedures for treatment of ectopic pregnancy Aspiration of breast masses Tier A Bladder biopsy and diathermy Tier A Cervical biopsy Tier A Colpocleisis Tier A Colpoplasty Tier A Colposcopy Tier A Consulting Tier A Cystoscopic injection of Botulinum Toxin Tier A Cystoscopy as part of gynaecological procedure Tier A D&C for abortion Tier A Delayed anal sphincter repair Tier A Diagnostic laparoscopy Tier A Endometrial ablation Tier A Exploratory laparotomy, for diagnosis and treatment of pelvic pain, pelvic mass, Tier A hemoperitoneum, endometriosis and adhesions Gynaecological sonography Tier A Hysterectomy, abdominal, vaginal, excluding laparoscopic Tier A Hysterosalpingography Tier A Hysteroscopic surgery Tier A Hysteroscopy Tier A I&D of bartholin cyst or perineal abscess Tier A I&D of pelvic abscess Tier A Incidental appendectomy Tier A Insertion and removal of IUCD Tier A Intrauterine myomectomy with power morcellation by hysteroscopic approach Tier A Laparoscopic surgery (excludes laparoscopic myomectomy with power morcellation) Tier A Laparotomy Tier A Marsupialisation of bartholin cysts Tier A Minor gynaecological surgical procedures (endometrial biopsy, dilation and curettage, Tier A treatment of Bartholin cyst and abscess) Myomectomy Tier A Operation for treatment of
  • Case Report Uterine Fibroid Torsion During Pregnancy: a Case of Laparotomic Myomectomy at 18 Weeks’ Gestation with Systematic Review of the Literature

    Case Report Uterine Fibroid Torsion During Pregnancy: a Case of Laparotomic Myomectomy at 18 Weeks’ Gestation with Systematic Review of the Literature

    Hindawi Case Reports in Obstetrics and Gynecology Volume 2017, Article ID 4970802, 11 pages https://doi.org/10.1155/2017/4970802 Case Report Uterine Fibroid Torsion during Pregnancy: A Case of Laparotomic Myomectomy at 18 Weeks’ Gestation with Systematic Review of the Literature Annachiara Basso,1 Mariana Rita Catalano,1 Giuseppe Loverro,1 Serena Nocera,1 Edoardo Di Naro,1 Matteo Loverro,1 Mariateresa Natrella,2 and Salvatore Andrea Mastrolia1 1 Department of Obstetrics and Gynecology, Azienda Ospedaliera Universitaria Policlinico di Bari, School of Medicine, UniversitadegliStudidiBari“AldoMoro”,Bari,Italy` 2School of Nursing, Azienda Ospedaliera Universitaria Policlinico di Bari, School of Medicine, UniversitadegliStudidiBari“AldoMoro”,Bari,Italy` Correspondence should be addressed to Salvatore Andrea Mastrolia; [email protected] Received 15 January 2017; Revised 17 March 2017; Accepted 20 March 2017; Published 24 April 2017 Academic Editor: Maria Grazia Porpora Copyright © 2017 Annachiara Basso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Uterine myomas are the most common benign growths affecting female reproductive system, occurring in 20–40% of women, whereas the incidence rate in pregnancy is estimated from 0.1 to 3.9%. The lower incidence in pregnancy is due to the association with infertility and low pregnancy rates and implantation rates after in vitro fertilization treatment. Uterine myomas, usually, are asymptomatic during pregnancy. However, occasionally, pedunculated fibroids torsion or other superimposed complications may cause acute abdominal pain. There are many controversies in performing myomectomy during cesarean section because of the risk of hemorrhage.
  • Download Download

    Download Download

    Medical Research Archives. Volume 5, issue 6. June 2017. The evolution of gynecologic endoscopic surgery over 50 years – a pleasant adventure The evolution of gynecologic endoscopic surgery over 50 years – a pleasant adventure Author Liselotte Mettler Department of Obstetrics Abstract: and Gynaecology, Endoscopic surgery spans the wings from 1901 (Georg Kelling) till the cutting edge years with Raoul Palmer, Kurt University Hospitals Semm , Hans Frangenheim , Hans Lindemann and Jordan Schleswig-Holstein, Philipps in 1985 in gynecology , It did experience further multispecialitxy progress from 1985 – 2017 with higher Arnold-Heller-Str. 3, dexterity, precision , loss of anxiety, micro and robotic House 24, 24105 Kiel, surgery, single , multiple ports and robotic technology. The evolution has just begun and will lead to a bright future. The Campus Kiel, Germany, influence of industry, which has kept pace and actively Email: supported this development for years, is the driving force besides the heroes of doctors and engineers that bring up new [email protected] ideas. Without suitable technology, this dissemination would 1 Copyright 2017 KEI Journals. All Rights Reserved. Medical Research Archives. Volume 5, issue 6. June 2017. The evolution of gynecologic endoscopic surgery over 50 years – a pleasant adventure not have been possible. Endoscopic development and its future does depend on new inventions, on the audacity of leading heroes, their input into this field but also on their management of life to continue to survive and on a healthy and successful cooperation with the medical technical industry and the governments of our countries which grant us the freedom of research and development for the best of all our patients.
  • SJH Procedures

    SJH Procedures

    SJH Procedures - Gynecology and Gynecology Oncology Services New Name Old Name CPT Code Service ABLATION, LESION, CERVIX AND VULVA, USING CO2 LASER LASER VAPORIZATION CERVIX/VULVA W CO2 LASER 56501 Destruction of lesion(s), vulva; simple (eg, laser surgery, Gynecology electrosurgery, cryosurgery, chemosurgery) 56515 Destruction of lesion(s), vulva; extensive (eg, laser surgery, Gynecology electrosurgery, cryosurgery, chemosurgery) 57513 Cautery of cervix; laser ablation Gynecology BIOPSY OR EXCISION, LESION, FACE AND NECK EXCISION/BIOPSY (MASS/LESION/LIPOMA/CYST) FACE/NECK General, Gynecology, Plastics, ENT, Maxillofacial BIOPSY OR EXCISION, LESION, FACE AND NECK, 2 OR MORE EXCISE/BIOPSY (MASS/LESION/LIPOMA/CYST) MULTIPLE FACE/NECK 11102 Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); General, Gynecology, single lesion Aesthetics, Urology, Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11103 Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); General, Gynecology, each separate/additional lesion (list separately in addition to Aesthetics, Urology, code for primary procedure) Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11104 Punch biopsy of skin (including simple closure, when General, Gynecology, performed); single lesion Aesthetics, Urology, Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11105 Punch biopsy of skin (including simple closure, when General, Gynecology, performed); each separate/additional lesion
  • Uterine Fibroids and Sepsis

    Uterine Fibroids and Sepsis

    DISCLAIMER: Results of database and or Internet searches are subject to the limitations of both the database(s) searched, and by your search request. It is the responsibility of the requestor to determine the accuracy, validity and interpretation of the results. Date: 13 November 2018 Sources Searched: Embase, Medline. Uterine Fibroids and Sepsis See full search strategy 1. Spontaneous Ruptured Pyomyoma in a Nulligravid Female: A Case Report and Review of the Literature. Author(s): Read, S; Mullins, J Source: Case reports in obstetrics and gynecology; 2018; vol. 2018 ; p. 1026287 Publication Date: 2018 Publication Type(s): Journal Article PubMedID: 30057837 Available at Case reports in obstetrics and gynecology - from Europe PubMed Central - Open Access Abstract:IntroductionPyomyoma, or suppurative leiomyoma, is a rare complication of uterine fibroids. It occurs most commonly in the setting of pregnancy, the immediate postpartum period, or postmenopausal status. It may also arise after recent uterine instrumentation, after uterine artery embolization, or in immunocompromised patients. The most likely cause of pyomyoma is vascular compromise followed by bacterial seeding from direct, hematogenous, or lymphatic spread. Diagnosis is difficult, as the condition is rare, presents with vague symptoms, and is difficult to identify on imaging. Definitive diagnosis is only possible with surgery. Pathology shows a degenerating fibroid with hemorrhage, necrosis, cystic degeneration, and/or inflammatory change. Cultures of the pus contained within often show polymicrobial infection.Case PresentationOur patient is a 24-year-old nulligravid female who presented with a surgical abdomen, fever, hypotension, and leukocytosis. She had no significant prior medical or surgical history, no history of uterine instrumentation, and no history of pelvic infection; she was not currently sexually active at the time of presentation.
  • Wehealth Plus Benefit Schedule

    Wehealth Plus Benefit Schedule

    WeHealth Plus Benefit Schedule [Applicable to Scheme 1] Benefit items(1) Benefit limit (in HKD) (a) Room and board $1,000 per day Maximum 180 days per Policy Year (b) Miscellaneous charges $14,000 per Policy Year (c) Attending doctor's visit fee $750 per day Maximum 180 days per Policy Year (d) Specialist's fee(2) $4,300 per Policy Year (e) Intensive care $3,500 per day Maximum 25 days per Policy Year (f) Surgeon's fee Per surgery, subject to surgical category for the surgery/procedure in the Schedule of Surgical Procedures – • Complex $50,000 • Major $25,000 • Intermediate $12,500 • Minor $5,000 (g) Anaesthetist's fee 35% of Surgeon's fee payable (5) (h) Operating theatre charges 35% of Surgeon's fee payable (5) (i) Prescribed Diagnostic Imaging Tests(2) (3) $20,000 per Policy Year Subject to 30% Coinsurance (j) Prescribed Non-surgical Cancer $80,000 per Policy Year Treatments(4) (k) Pre- and post-Confinement/Day Case $580 per visit, up to $3,000 per Policy Year Procedure outpatient care (2) • 1 prior outpatient visit or Emergency consultation per Confinement/Day Case Procedure • 3 follow-up outpatient visits per Confinement/Day Case Procedure (within 90 days after discharge from Hospital or completion of Day Case Procedure) (l) Psychiatric treatments $30,000 per Policy Year Enhanced benefits (1) Home nursing benefit(2) $600 per day Below Age 60: Maximum 15 days per Policy Year Age 60 and/or above: Maximum 30 days per Policy Year (within 90 days after discharge from Hospital or completion of Day Case Procedure) (2) Kidney dialysis treatment benefit(2) $60,000 per Policy Year (Effective after 90 days from Policy Issuance Date / Policy Effective Date, whichever is earlier) (3) Emergency outpatient treatment benefit $5,000 per Policy Year (4) Cardiac rehabilitation treatment $10,000 per Policy Year benefit (2) (within 90 days after discharge from Hospital or completion of Day Case Procedure) The content on this page is part of the Terms and Benefits of Certified Plan (No.